To include your compound in the COVID-19 Resource Center, submit it here.

CHMP recommends Amgen's biosimilar Avastin

EMA's CHMP recommended approval of ABP 215 from Amgen Inc. (NASDAQ:AMGN),

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE